(Q37626927)

21 August 2017

A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses (English)

1 reference

21 August 2017

1 reference

3

Matthew Sandbulte

1 reference

21 August 2017

Maryna C Eichelberger

9

object named as

Maryna C Eichelberger

1 reference

21 August 2017

Arash Hassantoufighi

1

1 reference

21 August 2017

Henry Zhang

2

1 reference

21 August 2017

Jin Gao

4

1 reference

21 August 2017

Jody Manischewitz

5

1 reference

21 August 2017

Lisa King

6

1 reference

21 August 2017

Hana Golding

7

1 reference

21 August 2017

Timothy M Straight

8

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

28

1 reference

21 August 2017

3

1 reference

21 August 2017

790-797

1 reference

Determinants of immunity to influenza infection in man

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Measuring antibody responses to a live attenuated influenza vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

A DNA transfection system for generation of influenza A virus from eight plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Effect of neuraminidase antibody on Hong Kong influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

The determination of free sialic acid in the presence of the bound compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.066

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.10.066

1 reference

21 August 2017

1 reference